Mr. Kyle Frey, Quotient Sciences, United States
Mr. Kyle Frey is an exceptionally driven scientist and internationally recognized author with over 12 years of experience in pharmaceutical research and drug development. Specializing in formulation design, preformulation assessments, and manufacturing, he has contributed to advancements in pharmaceutical technologies, including resonant acoustic mixing (RAM) for low-dose blending. Kyle has been honored as a Distinguished Scientist by Marquis Who’s Who and is a sought-after technical expert in the field. With a strong foundation in medical school training at Thomas Jefferson Medical College, he excels in solving complex challenges and advancing innovations in pharmaceutical science.
Publication Profile
Orcid
Education
Kyle Frey pursued an ambitious academic journey, starting with his time at Thomas Jefferson Medical College, where he completed two years of coursework in the M.D. program (08/2010 – 12/2012). Although he did not obtain the degree, his education included in-depth studies in pharmacokinetics, biochemistry, molecular biology, anatomy, neurology, and immunology. Prior to this, he earned a Bachelor of Arts in Pre-Medicine from the University of Delaware (09/2006 – 05/2010), graduating summa cum laude with a 3.942 GPA. He was also a Phi Beta Kappa member, received a full scholarship for his last two years, and earned Dean’s List honors. 🎓
Experience
Kyle Frey is currently serving as a Formulation Scientist III at Quotient Sciences, where he has been since January 2020. His role involves assessing novel APIs using various characterization techniques such as thermal analysis, solubility, and bulk/physical tests. He leads preformulation activities, including excipient selection, compatibility testing, and stability studies, presenting findings and designing laboratory studies. Kyle also develops and optimizes pharmaceutical formulations, resolves formulation issues, and supports GMP manufacturing for clinical trials. He collaborates with cross-functional teams, prepares technical documents, and mentors junior scientists. His expertise includes working with high-potent molecules. 🔬💊
Research Focus
Kyle Frey’s research focuses on the innovative application of Resonant Acoustic Mixing Technology for enhancing the uniformity of low-dose pharmaceutical blends. This technology aims to streamline the process of blending ultra-low doses of active pharmaceutical ingredients (APIs) in a single-step mixing process, improving precision and reducing potential errors in dosage. His work is crucial in the fields of pharmaceutical engineering, formulation science, and drug delivery systems, where blending efficiency directly impacts drug effectiveness and patient safety. Frey’s contributions are pivotal in advancing pharmaceutical manufacturing technologies..
Publication Top Notes
Sample preparation techniques to enhance uniformity of Low-Dose blends mixed by resonant acoustic mixing technology